AI assistant
PROTHENA CORP PUBLIC LTD CO — Director's Dealing 2017
Sep 29, 2017
32782_dirs_2017-09-29_44f8ea22-c5e3-4a9a-8063-b5184f92001e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Prothena Corp plc (PRTA)
CIK: 0001559053
Period of Report: 2017-09-28
Reporting Person: Kinney Gene G. (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-09-28 | Ordinary Shares, par value $0.01 per share | M | 2800 | $6.41 | Acquired | 5593 | Direct |
| 2017-09-28 | Ordinary Shares, par value $0.01 per share | S | 2800 | $70.00 | Disposed | 2793 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-09-28 | Stock Option (right to buy) | $6.41 | M | 2800 | Disposed | 2023-01-29 | Ordinary Shares (2800) | Direct |
Footnotes
F1: The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person.
F2: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on January 29, 2014 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.